Review



pgbd5 plasmids  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Addgene inc pgbd5 plasmids
    Alignment of piggyBac and <t>PGBD5</t> protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.
    Pgbd5 Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pinducer21+pgbd5/pINDUCER21-PGBD5+(Plasmid+%2378121)/pmc08373079-36-0-5
    Average 92 stars, based on 1 article reviews
    pgbd5 plasmids - by Bioz Stars, 2026-09
    92/100 stars

    Images

    1) Product Images from "Cognate restriction of transposition by piggyBac- like proteins"

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gkab578

    Alignment of piggyBac and PGBD5 protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.
    Figure Legend Snippet: Alignment of piggyBac and PGBD5 protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.

    Techniques Used: Sequencing

    The pTpB piggyBac transposon is only excised and integrated by piggyBac in human cells. (A) Schematic of pTpB transposon conferring neomycin resistance. (B) Excision assay using pCMV-SB, -PB, -HyPBase, -pBat or -PGBD5 (pRecLV103-GFP-PGBD5) to express the putative transposase in HEK293 cells transfected with pTpB. The expected excision product is 539 bp. Shown is representative of three independent experiments. (C) Colony count analysis of various transposon:transposase (1 μg:1 μg, 1.8 μg:200 ng or 200 ng:1.8 μg pTpB:transposase) ratios in HEK293 cells using pUC (negative control) or PB/PGBD5; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HEK293 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.
    Figure Legend Snippet: The pTpB piggyBac transposon is only excised and integrated by piggyBac in human cells. (A) Schematic of pTpB transposon conferring neomycin resistance. (B) Excision assay using pCMV-SB, -PB, -HyPBase, -pBat or -PGBD5 (pRecLV103-GFP-PGBD5) to express the putative transposase in HEK293 cells transfected with pTpB. The expected excision product is 539 bp. Shown is representative of three independent experiments. (C) Colony count analysis of various transposon:transposase (1 μg:1 μg, 1.8 μg:200 ng or 200 ng:1.8 μg pTpB:transposase) ratios in HEK293 cells using pUC (negative control) or PB/PGBD5; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HEK293 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.

    Techniques Used: Excision Assay, Transfection, Negative Control, Stable Transfection, Control

    piggyBat transposons are only integrated by piggyBat in human cells. (A) Schematic of pTpBat transposon conferring neomycin resistance. (B) Colony count analysis measuring integration efficiency of pTpBat in HEK293 cells by pUC (negative control), pCMV-PB, pRecLV103-GFP-PGBD5, or pCMV-pBat; N = 3 ± SD; *, P< 0.05.
    Figure Legend Snippet: piggyBat transposons are only integrated by piggyBat in human cells. (A) Schematic of pTpBat transposon conferring neomycin resistance. (B) Colony count analysis measuring integration efficiency of pTpBat in HEK293 cells by pUC (negative control), pCMV-PB, pRecLV103-GFP-PGBD5, or pCMV-pBat; N = 3 ± SD; *, P< 0.05.

    Techniques Used: Negative Control

    piggyBac, but not PGBD5, binds the piggyBac ITR using reporter readout of protein-DNA interaction in transfected cells. (A) Schematic demonstrating that transposase (PB (+ control), GFP (− control) or PGBD5 fused to a VPR activation domain. If binding to the LE (left end) or flipped LE (rLE, reverse LE) ITR occurs, luciferase is expressed and can be measured by IVIS imaging and quantified. (B) IVIS imaging of transfected cells. (C) Photons/s (p/s) readout of transposase ITR interaction; N = 3 ± SD. *, P< 0.05 compared to GFP control.
    Figure Legend Snippet: piggyBac, but not PGBD5, binds the piggyBac ITR using reporter readout of protein-DNA interaction in transfected cells. (A) Schematic demonstrating that transposase (PB (+ control), GFP (− control) or PGBD5 fused to a VPR activation domain. If binding to the LE (left end) or flipped LE (rLE, reverse LE) ITR occurs, luciferase is expressed and can be measured by IVIS imaging and quantified. (B) IVIS imaging of transfected cells. (C) Photons/s (p/s) readout of transposase ITR interaction; N = 3 ± SD. *, P< 0.05 compared to GFP control.

    Techniques Used: Transfection, Control, Activation Assay, Binding Assay, Luciferase, Imaging

    Western blot analysis confirms correct expression of piggyBac and PGBD5 in HEK293 cells. HA-PGBD5v1 and v2 have expected molecular weight of 52 and 58 kDa, respectively. The pInducer plasmids lack an HA tag and serve as negative control. HA-tagged (sodium hydrogen exchanger 3) NHE3 and PB serve as positive controls. Blot demonstrates HA (green) with B actin (red) serving as a loading control confirming equal total protein input for each lane.
    Figure Legend Snippet: Western blot analysis confirms correct expression of piggyBac and PGBD5 in HEK293 cells. HA-PGBD5v1 and v2 have expected molecular weight of 52 and 58 kDa, respectively. The pInducer plasmids lack an HA tag and serve as negative control. HA-tagged (sodium hydrogen exchanger 3) NHE3 and PB serve as positive controls. Blot demonstrates HA (green) with B actin (red) serving as a loading control confirming equal total protein input for each lane.

    Techniques Used: Western Blot, Expressing, Molecular Weight, Negative Control, Control

    piggyBac, and not PGBD5, integrates PB-EF1-NEO, μpTpB and iμpTpB (i, inverted) transposon vectors. (A) Schematic of μpTpB with shortened ITRs, and iμpTpB with shortened ITRs in flipped orientation (to correspond to PB-EF1-NEO), conferring neomycin resistance. (B) Colony count analysis of G418 resistance in HT-1080 cells transfected with PB-EF1-NEO and pUC, pCMV-SB, pCMV-pB, or pRecLV103-GFP-PGBD5; N = 3 ± SD; *, P< 0.05. (C) Colony count analysis after transfection of the various transposon and transposase vectors into HT-1080 cells and subsequently selected with G418; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HT-1080 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.
    Figure Legend Snippet: piggyBac, and not PGBD5, integrates PB-EF1-NEO, μpTpB and iμpTpB (i, inverted) transposon vectors. (A) Schematic of μpTpB with shortened ITRs, and iμpTpB with shortened ITRs in flipped orientation (to correspond to PB-EF1-NEO), conferring neomycin resistance. (B) Colony count analysis of G418 resistance in HT-1080 cells transfected with PB-EF1-NEO and pUC, pCMV-SB, pCMV-pB, or pRecLV103-GFP-PGBD5; N = 3 ± SD; *, P< 0.05. (C) Colony count analysis after transfection of the various transposon and transposase vectors into HT-1080 cells and subsequently selected with G418; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HT-1080 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.

    Techniques Used: Transfection, Stable Transfection, Control

    Plasmid rescue of transposon integration sites in the human genome
    Figure Legend Snippet: Plasmid rescue of transposon integration sites in the human genome

    Techniques Used: Plasmid Preparation

    Related Articles

    other:

    Article Title: Cognate restriction of transposition by piggyBac- like proteins
    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).



    Similar Products

    92
    Addgene inc pgbd5 plasmids
    Alignment of piggyBac and <t>PGBD5</t> protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.
    Pgbd5 Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pinducer21+pgbd5/pINDUCER21-PGBD5+(Plasmid+%2378121)/pmc08373079-36-0-5
    Average 92 stars, based on 1 article reviews
    pgbd5 plasmids - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pinducer21 pgbd5
    Alignment of piggyBac and <t>PGBD5</t> protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.
    Pinducer21 Pgbd5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pinducer21+pgbd5/pINDUCER21-PGBD5+(Plasmid+%2378121)/pmc08373079-77-7-5
    Average 92 stars, based on 1 article reviews
    pinducer21 pgbd5 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    Image Search Results


    Alignment of piggyBac and PGBD5 protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: Alignment of piggyBac and PGBD5 protein sequences as described in the Materials and Methods section. Identical amino acids are highlighted in green. The DDD catalytic motif of piggyBac is marked with black bars above the amino acids. The CRD of piggyBac is underlined in red and then expanded to demonstrate the bipartite nuclear localization sequence (underlined black) and cystine residues of the CRD (highlighted red). PGBD5, version 1; PGBD5.2, version 2.

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Sequencing

    The pTpB piggyBac transposon is only excised and integrated by piggyBac in human cells. (A) Schematic of pTpB transposon conferring neomycin resistance. (B) Excision assay using pCMV-SB, -PB, -HyPBase, -pBat or -PGBD5 (pRecLV103-GFP-PGBD5) to express the putative transposase in HEK293 cells transfected with pTpB. The expected excision product is 539 bp. Shown is representative of three independent experiments. (C) Colony count analysis of various transposon:transposase (1 μg:1 μg, 1.8 μg:200 ng or 200 ng:1.8 μg pTpB:transposase) ratios in HEK293 cells using pUC (negative control) or PB/PGBD5; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HEK293 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: The pTpB piggyBac transposon is only excised and integrated by piggyBac in human cells. (A) Schematic of pTpB transposon conferring neomycin resistance. (B) Excision assay using pCMV-SB, -PB, -HyPBase, -pBat or -PGBD5 (pRecLV103-GFP-PGBD5) to express the putative transposase in HEK293 cells transfected with pTpB. The expected excision product is 539 bp. Shown is representative of three independent experiments. (C) Colony count analysis of various transposon:transposase (1 μg:1 μg, 1.8 μg:200 ng or 200 ng:1.8 μg pTpB:transposase) ratios in HEK293 cells using pUC (negative control) or PB/PGBD5; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HEK293 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Excision Assay, Transfection, Negative Control, Stable Transfection, Control

    piggyBat transposons are only integrated by piggyBat in human cells. (A) Schematic of pTpBat transposon conferring neomycin resistance. (B) Colony count analysis measuring integration efficiency of pTpBat in HEK293 cells by pUC (negative control), pCMV-PB, pRecLV103-GFP-PGBD5, or pCMV-pBat; N = 3 ± SD; *, P< 0.05.

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: piggyBat transposons are only integrated by piggyBat in human cells. (A) Schematic of pTpBat transposon conferring neomycin resistance. (B) Colony count analysis measuring integration efficiency of pTpBat in HEK293 cells by pUC (negative control), pCMV-PB, pRecLV103-GFP-PGBD5, or pCMV-pBat; N = 3 ± SD; *, P< 0.05.

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Negative Control

    piggyBac, but not PGBD5, binds the piggyBac ITR using reporter readout of protein-DNA interaction in transfected cells. (A) Schematic demonstrating that transposase (PB (+ control), GFP (− control) or PGBD5 fused to a VPR activation domain. If binding to the LE (left end) or flipped LE (rLE, reverse LE) ITR occurs, luciferase is expressed and can be measured by IVIS imaging and quantified. (B) IVIS imaging of transfected cells. (C) Photons/s (p/s) readout of transposase ITR interaction; N = 3 ± SD. *, P< 0.05 compared to GFP control.

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: piggyBac, but not PGBD5, binds the piggyBac ITR using reporter readout of protein-DNA interaction in transfected cells. (A) Schematic demonstrating that transposase (PB (+ control), GFP (− control) or PGBD5 fused to a VPR activation domain. If binding to the LE (left end) or flipped LE (rLE, reverse LE) ITR occurs, luciferase is expressed and can be measured by IVIS imaging and quantified. (B) IVIS imaging of transfected cells. (C) Photons/s (p/s) readout of transposase ITR interaction; N = 3 ± SD. *, P< 0.05 compared to GFP control.

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Transfection, Control, Activation Assay, Binding Assay, Luciferase, Imaging

    Western blot analysis confirms correct expression of piggyBac and PGBD5 in HEK293 cells. HA-PGBD5v1 and v2 have expected molecular weight of 52 and 58 kDa, respectively. The pInducer plasmids lack an HA tag and serve as negative control. HA-tagged (sodium hydrogen exchanger 3) NHE3 and PB serve as positive controls. Blot demonstrates HA (green) with B actin (red) serving as a loading control confirming equal total protein input for each lane.

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: Western blot analysis confirms correct expression of piggyBac and PGBD5 in HEK293 cells. HA-PGBD5v1 and v2 have expected molecular weight of 52 and 58 kDa, respectively. The pInducer plasmids lack an HA tag and serve as negative control. HA-tagged (sodium hydrogen exchanger 3) NHE3 and PB serve as positive controls. Blot demonstrates HA (green) with B actin (red) serving as a loading control confirming equal total protein input for each lane.

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Western Blot, Expressing, Molecular Weight, Negative Control, Control

    piggyBac, and not PGBD5, integrates PB-EF1-NEO, μpTpB and iμpTpB (i, inverted) transposon vectors. (A) Schematic of μpTpB with shortened ITRs, and iμpTpB with shortened ITRs in flipped orientation (to correspond to PB-EF1-NEO), conferring neomycin resistance. (B) Colony count analysis of G418 resistance in HT-1080 cells transfected with PB-EF1-NEO and pUC, pCMV-SB, pCMV-pB, or pRecLV103-GFP-PGBD5; N = 3 ± SD; *, P< 0.05. (C) Colony count analysis after transfection of the various transposon and transposase vectors into HT-1080 cells and subsequently selected with G418; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HT-1080 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: piggyBac, and not PGBD5, integrates PB-EF1-NEO, μpTpB and iμpTpB (i, inverted) transposon vectors. (A) Schematic of μpTpB with shortened ITRs, and iμpTpB with shortened ITRs in flipped orientation (to correspond to PB-EF1-NEO), conferring neomycin resistance. (B) Colony count analysis of G418 resistance in HT-1080 cells transfected with PB-EF1-NEO and pUC, pCMV-SB, pCMV-pB, or pRecLV103-GFP-PGBD5; N = 3 ± SD; *, P< 0.05. (C) Colony count analysis after transfection of the various transposon and transposase vectors into HT-1080 cells and subsequently selected with G418; N = 3 ± SD; *, P< 0.05. (D) qPCR of copies of piggyBac ITR/RNAse P of 1 μg:1 μg pTpB:transposase stably transfected HT-1080 cells; N = 2 (in triplicate) ± SD; *, P< 0.05 compared to pUC control.

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Transfection, Stable Transfection, Control

    Plasmid rescue of transposon integration sites in the human genome

    Journal: Nucleic Acids Research

    Article Title: Cognate restriction of transposition by piggyBac- like proteins

    doi: 10.1093/nar/gkab578

    Figure Lengend Snippet: Plasmid rescue of transposon integration sites in the human genome

    Article Snippet: PGBD5 plasmids were obtained from Addgene including pINDUCER21-PGBD5 (#78121) and pRecLV103-GFP-PGBD5 (#65409) ( 13 ).

    Techniques: Plasmid Preparation